Alfresa Holdings Corporation (ALFRY)

Market Cap	2.50B -6.9%
Revenue (ttm)	19.29B +4.6%
Net Income	241.27M +40.3%
EPS	1.37 +42.8%
Shares Out	n/a
PE Ratio	11.52
Forward PE	n/a
Dividend	0.45 (2.85%)
Ex-Dividend Date	Mar 30, 2027

Volume	100
Open	15.82
Previous Close	15.82
Day's Range	15.82 - 15.82
52-Week Range	12.73 - 16.81
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. The company operates through Wholesale of Prescription Drugs and Related Products, Wholesale of Self-Medication Products, Manufacturing of Pharmaceuticals and Related Products, and Pharmacy and Related Businesses segments. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethic...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,525
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALFRY

Financial Performance

In fiscal year 2026, Alfresa Holdings's revenue was 3.10 trillion, an increase of 4.83% compared to the previous year's 2.96 trillion. Earnings were 41.75 billion, an increase of 52.42%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error